Onaitis Matthew

SVP, General Counsel at Somaxon Pharmaceuticals, Inc. · on record since Apr 5, 2010
Gnrl Counsel, CFO & Secretary at Cidara Therapeutics, Inc. · on record since Jul 5, 2016
General Counsel at Trius Therapeutics Inc · on record since Jun 3, 2013
General Counsel and Secretary at Ignyta, Inc. · on record since Mar 13, 2014

Insider trading activity of Onaitis Matthew

Transactions on record: 71; since Aug 23, 2006

Open-market buys: 0

Open-market sells: 8; $582.1K

Companies traded: 4; last filing Apr 2, 2018

Figures computed from official regulatory filings — methodology.

Companies where Onaitis Matthew has traded

Cidara Therapeutics, Inc.5 tx · Apr 2, 2018
Ignyta, Inc.3 tx · Jan 11, 2016
Trius Therapeutics Inc2 tx · $583K · Sep 13, 2013
Somaxon Pharmaceuticals, Inc.61 tx · $759.3K · Mar 8, 2013

Track record of Onaitis Matthew

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Onaitis Matthew

Co-insiders of Onaitis Matthew

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Cidara Therapeutics, Inc.	Apr 2, 2018	AwardD	72,000	0.00 USD	$0	SEC
Cidara Therapeutics, Inc.	Sep 19, 2017	Award	15,000	0.00 USD	$0	SEC
Cidara Therapeutics, Inc.	Sep 19, 2017	ExerciseD	25,000	0.00 USD	$0	SEC
Cidara Therapeutics, Inc.	Apr 4, 2017	AwardD	55,000	0.00 USD	$0	SEC
Cidara Therapeutics, Inc.	Jul 5, 2016	AwardD	110,000	0.00 USD	$0	SEC
Ignyta, Inc.	Jan 11, 2016	Award	26,400	0.00 USD	$0	SEC
Ignyta, Inc.	Jan 9, 2015	Award	20,000	0.00 USD	$0	SEC
Ignyta, Inc.	Jan 9, 2015	AwardD	44,160	0.00 USD	$0	SEC
Trius Therapeutics Inc	Sep 13, 2013	OtherD	-100,000	5.83 USD	$583K	SEC
Trius Therapeutics Inc	Jun 3, 2013	AwardD	100,000	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Mar 8, 2013	Other	-47,098	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Jan 3, 2013	Award	1,494	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Nov 20, 2012	Award	30,000	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Oct 2, 2012	Award	15,716	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Jul 3, 2012	Award	15,992	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Jan 4, 2012	Sell	-9,000	0.48 USD	$4.3K	SEC
Somaxon Pharmaceuticals, Inc.	Mar 9, 2011	AwardD	100,000	—	—	SEC
Somaxon Pharmaceuticals, Inc.	Mar 9, 2011	Award	50,000	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Mar 9, 2011	Award	30,000	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Dec 3, 2010	Sell	-8,468	2.68 USD	$22.7K	SEC
Somaxon Pharmaceuticals, Inc.	Apr 5, 2010	Award	30,000	0.00	$0	SEC
Somaxon Pharmaceuticals, Inc.	Apr 5, 2010	AwardD	100,000	—	—	SEC
Somaxon Pharmaceuticals, Inc.	Mar 22, 2010	Sell	-15,000	6.59	$98.9K	SEC
Somaxon Pharmaceuticals, Inc.	Mar 22, 2010	Exercise	17,945	1.23	$22.1K	SEC
Somaxon Pharmaceuticals, Inc.	Mar 22, 2010	ExerciseD	-1,111	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Cidara Therapeutics, Inc.	Apr 2, 2018	AwardD	72,000	0.00 USD	$0	SEC
Cidara Therapeutics, Inc.	Sep 19, 2017	Award	15,000	0.00 USD	$0	SEC
Cidara Therapeutics, Inc.	Sep 19, 2017	ExerciseD	25,000	0.00 USD	$0	SEC
Cidara Therapeutics, Inc.	Apr 4, 2017	AwardD	55,000	0.00 USD	$0	SEC
Cidara Therapeutics, Inc.	Jul 5, 2016	AwardD	110,000	0.00 USD	$0	SEC
Ignyta, Inc.	Jan 11, 2016	Award	26,400	0.00 USD	$0	SEC
Ignyta, Inc.	Jan 9, 2015	Award	20,000	0.00 USD	$0	SEC
Ignyta, Inc.	Jan 9, 2015	AwardD	44,160	0.00 USD	$0	SEC
Trius Therapeutics Inc	Sep 13, 2013	OtherD	-100,000	5.83 USD	$583K	SEC
Trius Therapeutics Inc	Jun 3, 2013	AwardD	100,000	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Mar 8, 2013	Other	-47,098	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Jan 3, 2013	Award	1,494	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Nov 20, 2012	Award	30,000	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Oct 2, 2012	Award	15,716	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Jul 3, 2012	Award	15,992	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Jan 4, 2012	Sell	-9,000	0.48 USD	$4.3K	SEC
Somaxon Pharmaceuticals, Inc.	Mar 9, 2011	AwardD	100,000	—	—	SEC
Somaxon Pharmaceuticals, Inc.	Mar 9, 2011	Award	50,000	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Mar 9, 2011	Award	30,000	0.00 USD	$0	SEC
Somaxon Pharmaceuticals, Inc.	Dec 3, 2010	Sell	-8,468	2.68 USD	$22.7K	SEC
Somaxon Pharmaceuticals, Inc.	Apr 5, 2010	Award	30,000	0.00	$0	SEC
Somaxon Pharmaceuticals, Inc.	Apr 5, 2010	AwardD	100,000	—	—	SEC
Somaxon Pharmaceuticals, Inc.	Mar 22, 2010	Sell	-15,000	6.59	$98.9K	SEC
Somaxon Pharmaceuticals, Inc.	Mar 22, 2010	Exercise	17,945	1.23	$22.1K	SEC
Somaxon Pharmaceuticals, Inc.	Mar 22, 2010	ExerciseD	-1,111	—	—	SEC